Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer
Aptamers provide a potential source of alternative targeting molecules for existing antibody diagnostics and therapeutics. In this work, we selected novel DNA aptamers targeting the HER2 receptor by an adherent whole-cell SELEX approach. Individual aptamers were identified by next generation sequenc...
Main Authors: | Marlies Gijs, Gregory Penner, Garth B. Blackler, Nathalie R.E.N. Impens, Sarah Baatout, André Luxen, An M. Aerts |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-05-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/9/2/29 |
Similar Items
-
Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer
by: Xiaolin Yu, et al.
Published: (2018-03-01) -
Development of HER2-Specific Aptamer-Drug Conjugate for Breast Cancer Therapy
by: Hwa Yeon Jeong, et al.
Published: (2020-12-01) -
DNA Aptamers in the Diagnosis and Treatment of Human Diseases
by: Qinchang Zhu, et al.
Published: (2015-11-01) -
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive <it>Breast</it> Cancer Cells <it>in Vitro</it>
by: Liu Zhe, et al.
Published: (2012-07-01) -
Aptamers: An Emerging Tool for Diagnosis and Therapeutics in Tuberculosis
by: Shruti Srivastava, et al.
Published: (2021-07-01)